Low‐dose ketamine infusions reduce opioid use in pediatric and young adult oncology patients Article Swipe
Doralina L. Anghelescu
,
Stephanie Ryan
,
Diana Wu
,
Kyle J. Morgan
,
Tushar Patni
,
Yimei Li
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1002/pbc.29693
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1002/pbc.29693
Background Ketamine is an NMDA‐receptor antagonist with analgesic and opioid‐sparing properties. Although well studied in adults, more robust evidence supporting ketamine's use for pediatric pain management is needed. This retrospective study evaluates ketamine's opioid‐sparing effectiveness in pediatric and young adult oncology and hematology patients. Procedure Continuous ketamine infusions administered for pain management between 2010–2020 were reviewed. Data including demographic characteristics, oncology/hematology and pain diagnoses, concurrent pain medications, and ketamine infusions’ dose and duration were collected. Opioid consumption data based on delivery via patient‐controlled analgesia were collected 1 day before (D1), all days during (cumulatively named D2), and 1 day after (D3) ketamine infusions and calculated as morphine‐equivalent doses (mg/kg/day). Data were reported for the entire study group as well as for distinct oncology and end‐of‐life categories, and short‐term acute pain circumstances which included vaso‐occlusive crises in hematology patients. Side effects were reviewed. Results Significantly lower daily opioid consumption was noted in the oncology group, while decreases were not significant in the end‐of‐life group and in the overall study population. The acute pain group did not show an opioid reduction associated with the ketamine infusions. A largely tolerable side‐effect profile was observed, with no differences among each group's incidence. Conclusions Ketamine infusions were associated with significantly reduced opioid consumption for oncology patients. The opioid‐sparing effects of ketamine may vary according to clinical diagnoses and circumstances of use. Overall, low‐dose ketamine infusions present an acceptable safety profile in pediatric and young adult patients; nevertheless, individual risks and benefits should be considered.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/pbc.29693
- OA Status
- green
- Cited By
- 14
- References
- 40
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4224066875
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4224066875Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/pbc.29693Digital Object Identifier
- Title
-
Low‐dose ketamine infusions reduce opioid use in pediatric and young adult oncology patientsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-04-04Full publication date if available
- Authors
-
Doralina L. Anghelescu, Stephanie Ryan, Diana Wu, Kyle J. Morgan, Tushar Patni, Yimei LiList of authors in order
- Landing page
-
https://doi.org/10.1002/pbc.29693Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/9329174Direct OA link when available
- Concepts
-
Ketamine, Medicine, Opioid, Morphine, Analgesic, Anesthesia, Incidence (geometry), Internal medicine, Retrospective cohort study, Receptor, Physics, OpticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
14Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 4, 2024: 4, 2023: 3, 2022: 3Per-year citation counts (last 5 years)
- References (count)
-
40Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4224066875 |
|---|---|
| doi | https://doi.org/10.1002/pbc.29693 |
| ids.doi | https://doi.org/10.1002/pbc.29693 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/35373875 |
| ids.openalex | https://openalex.org/W4224066875 |
| fwci | 4.95795865 |
| mesh[0].qualifier_ui | Q000188 |
| mesh[0].descriptor_ui | D059787 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | drug therapy |
| mesh[0].descriptor_name | Acute Pain |
| mesh[1].qualifier_ui | Q000627 |
| mesh[1].descriptor_ui | D000700 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | therapeutic use |
| mesh[1].descriptor_name | Analgesics |
| mesh[2].qualifier_ui | Q000627 |
| mesh[2].descriptor_ui | D000701 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | therapeutic use |
| mesh[2].descriptor_name | Analgesics, Opioid |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D002648 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Child |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D003643 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Death |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D006801 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Humans |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D007262 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Infusions, Intravenous |
| mesh[7].qualifier_ui | Q000627 |
| mesh[7].descriptor_ui | D007649 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | therapeutic use |
| mesh[7].descriptor_name | Ketamine |
| mesh[8].qualifier_ui | Q000627 |
| mesh[8].descriptor_ui | D009020 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | therapeutic use |
| mesh[8].descriptor_name | Morphine |
| mesh[9].qualifier_ui | Q000150 |
| mesh[9].descriptor_ui | D009369 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | complications |
| mesh[9].descriptor_name | Neoplasms |
| mesh[10].qualifier_ui | Q000188 |
| mesh[10].descriptor_ui | D009369 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | drug therapy |
| mesh[10].descriptor_name | Neoplasms |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D009293 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Opioid-Related Disorders |
| mesh[12].qualifier_ui | Q000139 |
| mesh[12].descriptor_ui | D010149 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | chemically induced |
| mesh[12].descriptor_name | Pain, Postoperative |
| mesh[13].qualifier_ui | Q000188 |
| mesh[13].descriptor_ui | D010149 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | drug therapy |
| mesh[13].descriptor_name | Pain, Postoperative |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D012189 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Retrospective Studies |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D055815 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Young Adult |
| mesh[16].qualifier_ui | Q000188 |
| mesh[16].descriptor_ui | D059787 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | drug therapy |
| mesh[16].descriptor_name | Acute Pain |
| mesh[17].qualifier_ui | Q000627 |
| mesh[17].descriptor_ui | D000700 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | therapeutic use |
| mesh[17].descriptor_name | Analgesics |
| mesh[18].qualifier_ui | Q000627 |
| mesh[18].descriptor_ui | D000701 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | therapeutic use |
| mesh[18].descriptor_name | Analgesics, Opioid |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D002648 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Child |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D003643 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Death |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D006801 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Humans |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D007262 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Infusions, Intravenous |
| mesh[23].qualifier_ui | Q000627 |
| mesh[23].descriptor_ui | D007649 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | therapeutic use |
| mesh[23].descriptor_name | Ketamine |
| mesh[24].qualifier_ui | Q000627 |
| mesh[24].descriptor_ui | D009020 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | therapeutic use |
| mesh[24].descriptor_name | Morphine |
| mesh[25].qualifier_ui | Q000150 |
| mesh[25].descriptor_ui | D009369 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | complications |
| mesh[25].descriptor_name | Neoplasms |
| mesh[26].qualifier_ui | Q000188 |
| mesh[26].descriptor_ui | D009369 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | drug therapy |
| mesh[26].descriptor_name | Neoplasms |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D009293 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Opioid-Related Disorders |
| mesh[28].qualifier_ui | Q000139 |
| mesh[28].descriptor_ui | D010149 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | chemically induced |
| mesh[28].descriptor_name | Pain, Postoperative |
| mesh[29].qualifier_ui | Q000188 |
| mesh[29].descriptor_ui | D010149 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | drug therapy |
| mesh[29].descriptor_name | Pain, Postoperative |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D012189 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Retrospective Studies |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D055815 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Young Adult |
| type | article |
| title | Low‐dose ketamine infusions reduce opioid use in pediatric and young adult oncology patients |
| biblio.issue | 9 |
| biblio.volume | 69 |
| biblio.last_page | e29693 |
| biblio.first_page | e29693 |
| topics[0].id | https://openalex.org/T10436 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9993000030517578 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2703 |
| topics[0].subfield.display_name | Anesthesiology and Pain Medicine |
| topics[0].display_name | Anesthesia and Sedative Agents |
| topics[1].id | https://openalex.org/T11292 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9991999864578247 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2735 |
| topics[1].subfield.display_name | Pediatrics, Perinatology and Child Health |
| topics[1].display_name | Pediatric Pain Management Techniques |
| topics[2].id | https://openalex.org/T10867 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9990000128746033 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2706 |
| topics[2].subfield.display_name | Critical Care and Intensive Care Medicine |
| topics[2].display_name | Intensive Care Unit Cognitive Disorders |
| is_xpac | False |
| apc_list.value | 4330 |
| apc_list.currency | USD |
| apc_list.value_usd | 4330 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2780795376 |
| concepts[0].level | 2 |
| concepts[0].score | 0.9413708448410034 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q243547 |
| concepts[0].display_name | Ketamine |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.9357141852378845 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2781063702 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7021775841712952 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q427523 |
| concepts[2].display_name | Opioid |
| concepts[3].id | https://openalex.org/C2777389121 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5262460112571716 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q81225 |
| concepts[3].display_name | Morphine |
| concepts[4].id | https://openalex.org/C2780820201 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5015995502471924 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q173235 |
| concepts[4].display_name | Analgesic |
| concepts[5].id | https://openalex.org/C42219234 |
| concepts[5].level | 1 |
| concepts[5].score | 0.4974112808704376 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q131130 |
| concepts[5].display_name | Anesthesia |
| concepts[6].id | https://openalex.org/C61511704 |
| concepts[6].level | 2 |
| concepts[6].score | 0.44781211018562317 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1671857 |
| concepts[6].display_name | Incidence (geometry) |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.42294520139694214 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| concepts[8].id | https://openalex.org/C167135981 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4156690537929535 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2146302 |
| concepts[8].display_name | Retrospective cohort study |
| concepts[9].id | https://openalex.org/C170493617 |
| concepts[9].level | 2 |
| concepts[9].score | 0.053388774394989014 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[9].display_name | Receptor |
| concepts[10].id | https://openalex.org/C121332964 |
| concepts[10].level | 0 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[10].display_name | Physics |
| concepts[11].id | https://openalex.org/C120665830 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q14620 |
| concepts[11].display_name | Optics |
| keywords[0].id | https://openalex.org/keywords/ketamine |
| keywords[0].score | 0.9413708448410034 |
| keywords[0].display_name | Ketamine |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.9357141852378845 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/opioid |
| keywords[2].score | 0.7021775841712952 |
| keywords[2].display_name | Opioid |
| keywords[3].id | https://openalex.org/keywords/morphine |
| keywords[3].score | 0.5262460112571716 |
| keywords[3].display_name | Morphine |
| keywords[4].id | https://openalex.org/keywords/analgesic |
| keywords[4].score | 0.5015995502471924 |
| keywords[4].display_name | Analgesic |
| keywords[5].id | https://openalex.org/keywords/anesthesia |
| keywords[5].score | 0.4974112808704376 |
| keywords[5].display_name | Anesthesia |
| keywords[6].id | https://openalex.org/keywords/incidence |
| keywords[6].score | 0.44781211018562317 |
| keywords[6].display_name | Incidence (geometry) |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.42294520139694214 |
| keywords[7].display_name | Internal medicine |
| keywords[8].id | https://openalex.org/keywords/retrospective-cohort-study |
| keywords[8].score | 0.4156690537929535 |
| keywords[8].display_name | Retrospective cohort study |
| keywords[9].id | https://openalex.org/keywords/receptor |
| keywords[9].score | 0.053388774394989014 |
| keywords[9].display_name | Receptor |
| language | en |
| locations[0].id | doi:10.1002/pbc.29693 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S119714264 |
| locations[0].source.issn | 1545-5009, 1545-5017 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1545-5009 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Pediatric Blood & Cancer |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Pediatric Blood & Cancer |
| locations[0].landing_page_url | https://doi.org/10.1002/pbc.29693 |
| locations[1].id | pmid:35373875 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Pediatric blood & cancer |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/35373875 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:9329174 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Pediatr Blood Cancer |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/9329174 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5074418371 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8521-2744 |
| authorships[0].author.display_name | Doralina L. Anghelescu |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1313298211 |
| authorships[0].affiliations[0].raw_affiliation_string | St. Jude Children's Research Hospital, Memphis, Tennessee |
| authorships[0].institutions[0].id | https://openalex.org/I1313298211 |
| authorships[0].institutions[0].ror | https://ror.org/02r3e0967 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I1313298211, https://openalex.org/I2802152183 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | St. Jude Children's Research Hospital |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Doralina L Anghelescu |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | St. Jude Children's Research Hospital, Memphis, Tennessee |
| authorships[1].author.id | https://openalex.org/A5109242764 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Stephanie Ryan |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1925986 |
| authorships[1].affiliations[0].raw_affiliation_string | Loyola University Chicago Stritch School of Medicine, Maywood, Illinois |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I1313298211 |
| authorships[1].affiliations[1].raw_affiliation_string | St. Jude Children's Research Hospital, Memphis, Tennessee |
| authorships[1].institutions[0].id | https://openalex.org/I1925986 |
| authorships[1].institutions[0].ror | https://ror.org/04b6x2g63 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I1925986 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Loyola University Chicago |
| authorships[1].institutions[1].id | https://openalex.org/I1313298211 |
| authorships[1].institutions[1].ror | https://ror.org/02r3e0967 |
| authorships[1].institutions[1].type | healthcare |
| authorships[1].institutions[1].lineage | https://openalex.org/I1313298211, https://openalex.org/I2802152183 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | St. Jude Children's Research Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Stephanie Ryan |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, St. Jude Children's Research Hospital, Memphis, Tennessee |
| authorships[2].author.id | https://openalex.org/A5103115775 |
| authorships[2].author.orcid | https://orcid.org/0009-0002-5771-2474 |
| authorships[2].author.display_name | Diana Wu |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1313298211 |
| authorships[2].affiliations[0].raw_affiliation_string | St. Jude Children's Research Hospital, Memphis, Tennessee |
| authorships[2].institutions[0].id | https://openalex.org/I1313298211 |
| authorships[2].institutions[0].ror | https://ror.org/02r3e0967 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I1313298211, https://openalex.org/I2802152183 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | St. Jude Children's Research Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Diana Wu |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | St. Jude Children's Research Hospital, Memphis, Tennessee |
| authorships[3].author.id | https://openalex.org/A5008085683 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-2031-3851 |
| authorships[3].author.display_name | Kyle J. Morgan |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1313298211 |
| authorships[3].affiliations[0].raw_affiliation_string | St. Jude Children's Research Hospital, Memphis, Tennessee |
| authorships[3].institutions[0].id | https://openalex.org/I1313298211 |
| authorships[3].institutions[0].ror | https://ror.org/02r3e0967 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I1313298211, https://openalex.org/I2802152183 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | St. Jude Children's Research Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Kyle J. Morgan |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | St. Jude Children's Research Hospital, Memphis, Tennessee |
| authorships[4].author.id | https://openalex.org/A5074209946 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-1605-7207 |
| authorships[4].author.display_name | Tushar Patni |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I1313298211 |
| authorships[4].affiliations[0].raw_affiliation_string | St. Jude Children's Research Hospital, Memphis, Tennessee |
| authorships[4].institutions[0].id | https://openalex.org/I1313298211 |
| authorships[4].institutions[0].ror | https://ror.org/02r3e0967 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I1313298211, https://openalex.org/I2802152183 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | St. Jude Children's Research Hospital |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Tushar Patni |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | St. Jude Children's Research Hospital, Memphis, Tennessee |
| authorships[5].author.id | https://openalex.org/A5101515155 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-7046-4316 |
| authorships[5].author.display_name | Yimei Li |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I1313298211 |
| authorships[5].affiliations[0].raw_affiliation_string | St. Jude Children's Research Hospital, Memphis, Tennessee |
| authorships[5].institutions[0].id | https://openalex.org/I1313298211 |
| authorships[5].institutions[0].ror | https://ror.org/02r3e0967 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I1313298211, https://openalex.org/I2802152183 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | St. Jude Children's Research Hospital |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Yimei Li |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | St. Jude Children's Research Hospital, Memphis, Tennessee |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/9329174 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Low‐dose ketamine infusions reduce opioid use in pediatric and young adult oncology patients |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10436 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9993000030517578 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2703 |
| primary_topic.subfield.display_name | Anesthesiology and Pain Medicine |
| primary_topic.display_name | Anesthesia and Sedative Agents |
| related_works | https://openalex.org/W2166188214, https://openalex.org/W2361408673, https://openalex.org/W68283621, https://openalex.org/W2012264476, https://openalex.org/W3113094104, https://openalex.org/W2437311625, https://openalex.org/W4243428330, https://openalex.org/W2467311807, https://openalex.org/W2409945781, https://openalex.org/W2761449271 |
| cited_by_count | 14 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 4 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 4 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 3 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 3 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:9329174 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Pediatr Blood Cancer |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/9329174 |
| primary_location.id | doi:10.1002/pbc.29693 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S119714264 |
| primary_location.source.issn | 1545-5009, 1545-5017 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1545-5009 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Pediatric Blood & Cancer |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Pediatric Blood & Cancer |
| primary_location.landing_page_url | https://doi.org/10.1002/pbc.29693 |
| publication_date | 2022-04-04 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W2947258170, https://openalex.org/W4211048968, https://openalex.org/W156686319, https://openalex.org/W3000401938, https://openalex.org/W2190481852, https://openalex.org/W2560570392, https://openalex.org/W7813333, https://openalex.org/W2040270811, https://openalex.org/W2559095492, https://openalex.org/W2154849873, https://openalex.org/W1893850715, https://openalex.org/W3145736315, https://openalex.org/W2153079225, https://openalex.org/W2089745007, https://openalex.org/W1858616525, https://openalex.org/W2959200555, https://openalex.org/W2745593899, https://openalex.org/W2949731702, https://openalex.org/W2604415576, https://openalex.org/W2000494198, https://openalex.org/W2019081365, https://openalex.org/W2028651779, https://openalex.org/W1900249832, https://openalex.org/W2329340405, https://openalex.org/W2789336217, https://openalex.org/W2884278957, https://openalex.org/W3003981729, https://openalex.org/W1493562807, https://openalex.org/W2053350806, https://openalex.org/W2141732025, https://openalex.org/W2183192066, https://openalex.org/W2003189601, https://openalex.org/W1982465464, https://openalex.org/W2023737863, https://openalex.org/W2891696658, https://openalex.org/W2806113917, https://openalex.org/W2100746119, https://openalex.org/W2570290090, https://openalex.org/W3046878669, https://openalex.org/W2968016740 |
| referenced_works_count | 40 |
| abstract_inverted_index.1 | 87, 98 |
| abstract_inverted_index.A | 185 |
| abstract_inverted_index.an | 4, 177, 232 |
| abstract_inverted_index.as | 106, 118, 120 |
| abstract_inverted_index.be | 248 |
| abstract_inverted_index.in | 15, 36, 136, 151, 160, 165, 236 |
| abstract_inverted_index.is | 3, 27 |
| abstract_inverted_index.no | 193 |
| abstract_inverted_index.of | 215, 225 |
| abstract_inverted_index.on | 80 |
| abstract_inverted_index.to | 220 |
| abstract_inverted_index.The | 170, 212 |
| abstract_inverted_index.all | 91 |
| abstract_inverted_index.and | 9, 38, 42, 62, 68, 72, 97, 104, 124, 127, 164, 223, 238, 245 |
| abstract_inverted_index.day | 88, 99 |
| abstract_inverted_index.did | 174 |
| abstract_inverted_index.for | 23, 50, 113, 121, 209 |
| abstract_inverted_index.may | 217 |
| abstract_inverted_index.not | 158, 175 |
| abstract_inverted_index.the | 114, 152, 161, 166, 182 |
| abstract_inverted_index.use | 22 |
| abstract_inverted_index.via | 82 |
| abstract_inverted_index.was | 149, 190 |
| abstract_inverted_index.(D3) | 101 |
| abstract_inverted_index.D2), | 96 |
| abstract_inverted_index.Data | 57, 110 |
| abstract_inverted_index.Side | 139 |
| abstract_inverted_index.This | 29 |
| abstract_inverted_index.data | 78 |
| abstract_inverted_index.days | 92 |
| abstract_inverted_index.dose | 71 |
| abstract_inverted_index.each | 196 |
| abstract_inverted_index.more | 17 |
| abstract_inverted_index.pain | 25, 51, 63, 66, 130, 172 |
| abstract_inverted_index.show | 176 |
| abstract_inverted_index.use. | 226 |
| abstract_inverted_index.vary | 218 |
| abstract_inverted_index.well | 13, 119 |
| abstract_inverted_index.were | 55, 74, 85, 111, 141, 157, 202 |
| abstract_inverted_index.with | 7, 181, 192, 204 |
| abstract_inverted_index.(D1), | 90 |
| abstract_inverted_index.acute | 129, 171 |
| abstract_inverted_index.adult | 40, 240 |
| abstract_inverted_index.after | 100 |
| abstract_inverted_index.among | 195 |
| abstract_inverted_index.based | 79 |
| abstract_inverted_index.daily | 146 |
| abstract_inverted_index.doses | 108 |
| abstract_inverted_index.group | 117, 163, 173 |
| abstract_inverted_index.lower | 145 |
| abstract_inverted_index.named | 95 |
| abstract_inverted_index.noted | 150 |
| abstract_inverted_index.risks | 244 |
| abstract_inverted_index.study | 31, 116, 168 |
| abstract_inverted_index.which | 132 |
| abstract_inverted_index.while | 155 |
| abstract_inverted_index.young | 39, 239 |
| abstract_inverted_index.Opioid | 76 |
| abstract_inverted_index.before | 89 |
| abstract_inverted_index.crises | 135 |
| abstract_inverted_index.during | 93 |
| abstract_inverted_index.entire | 115 |
| abstract_inverted_index.group, | 154 |
| abstract_inverted_index.opioid | 147, 178, 207 |
| abstract_inverted_index.robust | 18 |
| abstract_inverted_index.safety | 234 |
| abstract_inverted_index.should | 247 |
| abstract_inverted_index.Results | 143 |
| abstract_inverted_index.adults, | 16 |
| abstract_inverted_index.between | 53 |
| abstract_inverted_index.effects | 140, 214 |
| abstract_inverted_index.group's | 197 |
| abstract_inverted_index.largely | 186 |
| abstract_inverted_index.needed. | 28 |
| abstract_inverted_index.overall | 167 |
| abstract_inverted_index.present | 231 |
| abstract_inverted_index.profile | 189, 235 |
| abstract_inverted_index.reduced | 206 |
| abstract_inverted_index.studied | 14 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Although | 12 |
| abstract_inverted_index.Ketamine | 2, 200 |
| abstract_inverted_index.Overall, | 227 |
| abstract_inverted_index.benefits | 246 |
| abstract_inverted_index.clinical | 221 |
| abstract_inverted_index.delivery | 81 |
| abstract_inverted_index.distinct | 122 |
| abstract_inverted_index.duration | 73 |
| abstract_inverted_index.evidence | 19 |
| abstract_inverted_index.included | 133 |
| abstract_inverted_index.ketamine | 47, 69, 102, 183, 216, 229 |
| abstract_inverted_index.oncology | 41, 123, 153, 210 |
| abstract_inverted_index.reported | 112 |
| abstract_inverted_index.Procedure | 45 |
| abstract_inverted_index.according | 219 |
| abstract_inverted_index.analgesia | 84 |
| abstract_inverted_index.analgesic | 8 |
| abstract_inverted_index.collected | 86 |
| abstract_inverted_index.decreases | 156 |
| abstract_inverted_index.diagnoses | 222 |
| abstract_inverted_index.evaluates | 32 |
| abstract_inverted_index.including | 58 |
| abstract_inverted_index.infusions | 48, 103, 201, 230 |
| abstract_inverted_index.observed, | 191 |
| abstract_inverted_index.patients. | 44, 138, 211 |
| abstract_inverted_index.patients; | 241 |
| abstract_inverted_index.pediatric | 24, 37, 237 |
| abstract_inverted_index.reduction | 179 |
| abstract_inverted_index.reviewed. | 56, 142 |
| abstract_inverted_index.tolerable | 187 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Continuous | 46 |
| abstract_inverted_index.acceptable | 233 |
| abstract_inverted_index.antagonist | 6 |
| abstract_inverted_index.associated | 180, 203 |
| abstract_inverted_index.calculated | 105 |
| abstract_inverted_index.collected. | 75 |
| abstract_inverted_index.concurrent | 65 |
| abstract_inverted_index.diagnoses, | 64 |
| abstract_inverted_index.hematology | 43, 137 |
| abstract_inverted_index.incidence. | 198 |
| abstract_inverted_index.individual | 243 |
| abstract_inverted_index.infusions. | 184 |
| abstract_inverted_index.ketamine's | 21, 33 |
| abstract_inverted_index.low‐dose | 228 |
| abstract_inverted_index.management | 26, 52 |
| abstract_inverted_index.supporting | 20 |
| abstract_inverted_index.2010–2020 | 54 |
| abstract_inverted_index.Conclusions | 199 |
| abstract_inverted_index.categories, | 126 |
| abstract_inverted_index.considered. | 249 |
| abstract_inverted_index.consumption | 77, 148, 208 |
| abstract_inverted_index.demographic | 59 |
| abstract_inverted_index.differences | 194 |
| abstract_inverted_index.population. | 169 |
| abstract_inverted_index.properties. | 11 |
| abstract_inverted_index.significant | 159 |
| abstract_inverted_index.(mg/kg/day). | 109 |
| abstract_inverted_index.administered | 49 |
| abstract_inverted_index.infusions’ | 70 |
| abstract_inverted_index.medications, | 67 |
| abstract_inverted_index.short‐term | 128 |
| abstract_inverted_index.(cumulatively | 94 |
| abstract_inverted_index.Significantly | 144 |
| abstract_inverted_index.circumstances | 131, 224 |
| abstract_inverted_index.effectiveness | 35 |
| abstract_inverted_index.nevertheless, | 242 |
| abstract_inverted_index.retrospective | 30 |
| abstract_inverted_index.side‐effect | 188 |
| abstract_inverted_index.significantly | 205 |
| abstract_inverted_index.NMDA‐receptor | 5 |
| abstract_inverted_index.end‐of‐life | 125, 162 |
| abstract_inverted_index.characteristics, | 60 |
| abstract_inverted_index.opioid‐sparing | 10, 34, 213 |
| abstract_inverted_index.vaso‐occlusive | 134 |
| abstract_inverted_index.oncology/hematology | 61 |
| abstract_inverted_index.patient‐controlled | 83 |
| abstract_inverted_index.morphine‐equivalent | 107 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 96 |
| corresponding_author_ids | https://openalex.org/A5074418371 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| corresponding_institution_ids | https://openalex.org/I1313298211 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6399999856948853 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.93356025 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |